134 related articles for article (PubMed ID: 32151851)
1. A calcium channel or angiotensin converting enzyme inhibitor/angiotensin receptor blocker regime to reduced blood pressure variability in acute ischaemic stroke (CAARBS): A feasibility trial.
Davison WJ; Appiah K; Robinson TG; McGurgan IJ; Rothwell PM; Potter JF
J Neurol Sci; 2020 Jun; 413():116753. PubMed ID: 32151851
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial of a Calcium Channel or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Regime to Reduce Blood Pressure Variability following Ischaemic Stroke (CAARBS): a protocol for a feasibility study.
Robinson TG; Davison WJ; Rothwell PM; Potter JF
BMJ Open; 2019 Feb; 9(2):e025301. PubMed ID: 30782930
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
4. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
5. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
6. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
7. Does Antihypertensive Drug Class Affect Day-to-Day Variability of Self-Measured Home Blood Pressure? The HOMED-BP Study.
Asayama K; Ohkubo T; Hanazawa T; Watabe D; Hosaka M; Satoh M; Yasui D; Staessen JA; Imai Y;
J Am Heart Assoc; 2016 Mar; 5(3):e002995. PubMed ID: 27009620
[TBL] [Abstract][Full Text] [Related]
8. Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options.
Lüders S
Drugs; 2007; 67(7):955-63. PubMed ID: 17488141
[TBL] [Abstract][Full Text] [Related]
9. Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial.
Liu L; Xie X; Pan Y; Wang A; Wei Y; Liu J; Nie X; Liu D; Zhao Z; Wang P; Shen S; Zhong C; Xu T; Wang D; Wang GC; Song D; Ma Y; Zhao J; Jiang Y; Jing J; Meng X; Obst K; Chen CS; Wang D; Wang Y; Zhang Y; Wang Y; He J;
BMJ; 2023 Oct; 383():e076448. PubMed ID: 37813418
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan.
Omboni S; Volpe M
Adv Ther; 2019 Feb; 36(2):278-297. PubMed ID: 30591990
[TBL] [Abstract][Full Text] [Related]
11. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure management during acute ischaemic stroke.
Wityk RJ; Lewin JJ
Expert Opin Pharmacother; 2006 Feb; 7(3):247-58. PubMed ID: 16448319
[TBL] [Abstract][Full Text] [Related]
13. Paramedic Initiated Lisinopril For Acute Stroke Treatment (PIL-FAST): study protocol for a pilot randomised controlled trial.
Shaw L; Price C; McLure S; Howel D; McColl E; Ford GA
Trials; 2011 Jun; 12():152. PubMed ID: 21676221
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK).
Kiru G; Bicknell C; Falaschetti E; Powell J; Poulter N
Health Technol Assess; 2016 Jul; 20(59):1-180. PubMed ID: 27488944
[TBL] [Abstract][Full Text] [Related]
15. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
[TBL] [Abstract][Full Text] [Related]
16. Effect of antihypertensive agents on cerebral blood flow and flow velocity in acute ischaemic stroke: systematic review of controlled studies.
Sare GM; Gray LJ; Bath PM
J Hypertens; 2008 Jun; 26(6):1058-64. PubMed ID: 18475140
[TBL] [Abstract][Full Text] [Related]
17. High blood pressure in acute ischaemic stroke--broadening therapeutic horizons.
Sare GM; Geeganage C; Bath PM
Cerebrovasc Dis; 2009; 27 Suppl 1():156-61. PubMed ID: 19342846
[TBL] [Abstract][Full Text] [Related]
18. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA;
Trials; 2015 Dec; 16():581. PubMed ID: 26686682
[TBL] [Abstract][Full Text] [Related]
19. Arterial hypertension and ischaemic stroke.
Droste DW; Ritter MA; Dittrich R; Heidenreich S; Wichter T; Freund M; Ringelstein EB
Acta Neurol Scand; 2003 Apr; 107(4):241-51. PubMed ID: 12675696
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
Ovbiagele B; Kidwell CS; Starkman S; Selco SL; Rajajee V; Razinia T; Saver JL
Neurology; 2005 Sep; 65(6):851-4. PubMed ID: 16186522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
